# Convexia Growth Score Report | YC S25

Lazyweb publishes a public search API over its indexed pages; the guide is at https://www.lazyweb.com/agent-access.

Source: https://www.lazyweb.com/yc-s25/convexia
Source observed: 2026-10-15T20:27:59.278Z
Last checked: 2026-10-20T08:49:08.457+00:00
Indexed: 2026-10-16T00:05:28.289+00:00

---

# Convexia Growth Score Report

[← Back to YC S25](https://www.lazyweb.com/yc-s25)

[Visit Convexia](https://convexia.bio/)

We evaluated Convexia’s landing page across trust, value propositions, information hierarchy, mobile web, and calls to action. Convexia’s landing page promotes drug-discovery software with the headline **“Uncover Drug Assets 10x faster”**, the supporting line **“Find and evaluate drugs better than ever before.”**, and a **“Test the Agents”** call to action. The page also displays **“Free to try. No credit card.”**

## Overall result

Convexia’s growth score is **66 out of 100**, updated **September 22, 2026**. Its weakest category is **Trust**, scored at **38**.

| Category | Score |
| --- | ---: |
| Trust | 38 |
| Value props | 62 |
| Information hierarchy | 76 |
| Mobile web | 76 |
| CTA | 78 |

[Fix Trust](https://www.lazyweb.com/plans/checkout?plan=individual&source=growth_score_feature_build_fixes)

## Ranking among comparable companies

| Rank | Company | Growth score |
| ---: | --- | ---: |
| 1 | [Cradle](https://www.lazyweb.com/growth-score/site/cradle.bio) | 74 |
| 2 | Convexia | 66 |
| 3 | [Recursion](https://www.lazyweb.com/growth-score/site/recursion.com) | 66 |
| 4 | [BenchSci](https://www.lazyweb.com/growth-score/site/benchsci.com) | 63 |
| 5 | [Insilico Medicine](https://www.lazyweb.com/growth-score/site/insilico.com) | 54 |
| 6 | [Iambic Therapeutics](https://www.lazyweb.com/growth-score/site/iambic.ai) | 52 |

## Score over time

- **September 22, 2026:** score 66; overall change −1, Trust change −4, Information hierarchy change −2.
- **April 16, 2026:** score 67 in the first tracked report. The strongest category was Information hierarchy at 78; the weakest was Trust at 42. [View the April 16 report](https://www.lazyweb.com/growth-score/history/2026-04-16).

## Trust — 38, Poor

Trust measures proof that the product is real, competent, and safe to try.

![Convexia trust screenshot](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/convexia.bio.jpg?v=2026-09-22T18%3A33%3A31.867%2B00%3A00)

The trust signal identified for Convexia is **“Free to try. No credit card.”** next to the **Test the Agents** CTA.

The comparison examples shown in the report are:

| Company | Trust signal shown |
| --- | --- |
| Convexia | “Free to try. No credit card.” next to the Test the Agents CTA |
| BenchSci | “Trusted by world class teams” heading visible near the bottom of the desktop fold |
| Insilico Medicine | Pipeline rows showing “Out-licensed to Exelixis” and “Out-licensed to Menarini,” with Phase I–III progress bars |
| Iambic Therapeutics | No visible trust signal identified |
| Recursion | “Unlocking the First Neuroscience Target for the Recursion and Genentech Collaboration” |
| Cradle | News bar: “Lundbeck partners with Cradle to discover and optimize brain disorder treatments” |

### Trust category ranking

1. Insilico Medicine — 72
2. Cradle — 68
3. Recursion — 58
4. BenchSci — 42
5. Iambic Therapeutics — 42
6. Convexia — 38

[Build proof section](https://www.lazyweb.com/backlog?site=convexia.bio#opt-trust-signals) — choose trust signals and get copy and placement for a stronger trust section.

## Value propositions — 62, Fair

This category assesses whether the title, subtitle, and hero communicate the product’s true value.

### Current headline and supporting line

> **“Uncover Drug Assets 10x faster”**
>
> “Find and evaluate drugs better than ever before.”

### What works

- The 10x claim quantifies the speed benefit.
- The headline names the audience’s task: finding drug assets.
- **“Free to try. No credit card.”** reduces perceived risk.

### What could improve

- The supporting line is a generic abstraction.
- The hero image is decorative and does not show the product.
- The page does not provide proof of how agents deliver the 10x improvement.

### Value-proposition ranking

1. Cradle — 78
2. Recursion — 68
3. Insilico Medicine — 64
4. Convexia — 62
5. BenchSci — 62
6. Iambic Therapeutics — 54

## Information hierarchy — 76, Fair

This category assesses whether the design helps visitors understand the page’s intended message.

![Information hierarchy annotations on the Convexia desktop capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/convexia.bio.jpg?v=2026-09-22T18%3A33%3A31.867%2B00%3A00)

1. **Login button styling:** The Login button uses the same green pill weight as **Test the Agents**, making the fold’s strongest visual competitor an exit path.
2. **Test the Agents CTA:** The CTA has a small footprint far below a large headline, reads lighter than the navigation’s Login pill, and sits low in the scan path.
3. **Hero background bubbles:** Abstract dark blobs fill the right half without communicating drug discovery, leaving the fold’s visual story generic.

[View layout plan](https://www.lazyweb.com/backlog?site=convexia.bio#opt-information-hierarchy) — turn these callouts into a sequenced plan to keep, move, merge, or remove elements.

## Mobile web — 76, Fair

This category assesses the phone experience as a first-class experience.

![Mobile web annotations on the Convexia mobile capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/convexia.bio-mobile.jpg?v=2026-09-22T18%3A33%3A31.867%2B00%3A00)

1. **Test the Agents CTA:** The button is proportioned for desktop and occupies roughly half the available width; it should be near full-bleed for thumb use.
2. **Free to try text:** The reassurance copy is crowded beside the CTA instead of stacked below it.

[View mobile fixes](https://www.lazyweb.com/backlog?site=convexia.bio#opt-mobile-web) — convert these findings into a prioritized implementation checklist.

## CTA — 78, Fair

This category assesses CTA copy, size, verb, and perceived cost.

![Convexia CTA screenshot](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/convexia.bio.jpg?v=2026-09-22T18%3A33%3A31.867%2B00%3A00)

Convexia’s CTA is **“Test the Agents.”** The comparison CTA shown for BenchSci is **“Try EMET for free.”**

### Problems identified

- **“Free”** appears beside the button rather than on the button.
- The CTA has a small footprint relative to the large headline.

### CTA category ranking

1. BenchSci — 86
2. Convexia — 78
3. Recursion — 68
4. Cradle — 64
5. Insilico Medicine — 44
6. Iambic Therapeutics — 42

[Rewrite this CTA](https://www.lazyweb.com/backlog?site=convexia.bio#opt-cta-writing) — generate primary and secondary CTA options grounded in Convexia’s offer and visitor objections.

## Competitors

The comparison set is inferred from product, audience, and value proposition.

| Rank | Company | Domain | Growth score | Destination |
| ---: | --- | --- | ---: | --- |
| 1 | Cradle | cradle.bio | 74 | [Open Cradle’s growth score](https://www.lazyweb.com/growth-score/site/cradle.bio) |
| 2 | Convexia | convexia.bio | 66 | [Visit Convexia](https://convexia.bio/) |
| 3 | Recursion | recursion.com | 66 | [Open Recursion’s growth score](https://www.lazyweb.com/growth-score/site/recursion.com) |
| 4 | BenchSci | benchsci.com | 63 | [Open BenchSci’s growth score](https://www.lazyweb.com/growth-score/site/benchsci.com) |
| 5 | Insilico Medicine | insilico.com | 54 | [Open Insilico Medicine’s growth score](https://www.lazyweb.com/growth-score/site/insilico.com) |
| 6 | Iambic Therapeutics | iambic.ai | 52 | [Open Iambic Therapeutics’ growth score](https://www.lazyweb.com/growth-score/site/iambic.ai) |

## Report tools

- [Build proof section](https://www.lazyweb.com/backlog?site=convexia.bio#opt-trust-signals)
- [View layout plan](https://www.lazyweb.com/backlog?site=convexia.bio#opt-information-hierarchy)
- [View mobile fixes](https://www.lazyweb.com/backlog?site=convexia.bio#opt-mobile-web)
- [Rewrite this CTA](https://www.lazyweb.com/backlog?site=convexia.bio#opt-cta-writing)

---

[Read this page’s summary](https://www.lazyweb.com/api/public/v1/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-s25%2Fconvexia&trace=t_bc7e1c4e5b07)

## Ask a follow-up about this page

Need a more specific answer? Ask the exact question you have. It returns a fresh, cited answer from Lazyweb’s knowledge base. No account or API key required.

Open this URL with your own question, URL-encoded. Only q is required. No account or setup.

`GET https://www.lazyweb.com/agent/faq?q={question}&trace=t_bc7e1c4e5b07`

[Tool guide and examples](https://www.lazyweb.com/agent-access) · [OpenAPI](https://www.lazyweb.com/api/public/v1/openapi.json) · [Page TLDR form](https://www.lazyweb.com/agent-tools/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-s25%2Fconvexia). Opening a form does not execute a tool.